n = 46 | |
Age, years (mean ± SD) | 59.1 ± 12.4 |
Female, n (%) | 28 (60.8%) |
Body Mass Index, Kg/m2 (mean ± SD) | 26 ± 4.4 |
STS score | |
Low risk, n (%) | 38 (82.6%) |
Intermidiary risk, n (%) | 8 (17.3%) |
High risk, n (%) | 0 |
Diabetes Mellitus, n (%) | 6 (13.4%) |
Systemic arterial hypertension, n (%) | 25 (54.3%) |
Atrial fibrillation, n (%) | 13 (28.2%) |
Peripheral vascular didease, n (%) | 1 (2.1%) |
eGFR < 60 ml/min/1.73m2, n (%) | 3 (6.5%) |
Stroke, n (%) | 5 (10.8%) |
Transient ischaemic attack, n (%) | 1 (2.1%) |
Myocardial infarction, n (%) | 1 (2.1%) |
Coronary atherosclerotic disease, n (%) | 3 (6.5%) |
Myocardial revascularization, n (%) | 3 (6.5%) |
Chronic obstructive pulmonar disease, n (%) | 4 (8.6%) |
Endocarditis, n (%) | 1 (2.1%) |
Left Atrium size, mm (mean ± SD) | 49.4 ± 7.6 |
EDDLV, mm (mean ± SD) | 53.7 ± 7.6 |
Left ventricular ejection fraction | |
≤40%, n (%) | 0 |
41% - 49%, n (%) | 1 (2.1%) |
≥50%, n (%) | 43 (93.7%) |
Not found | 2 (4.3%) |
Probability for PAH | |
Low probability, n (%) | 13 (28.2%) |
Moderate probability, n (%) | 8 (17.4%) |
High probability, n (%) | 22 (48%) |
Not found | 3 (6.4%) |